US 8530167
Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering
granted A61PA61P43/00
Quick answer
US patent 8530167 (Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P43/00